Generation of Comparative Pharmacophoric Model for Steroidal 5α-Reductase I and II Inhibitors: A 3D-QSAR Study on 6-Azasteroids

January 2015 in “ Steroids ”

Suresh Thareja, Tarun Rajpoot, Sant Kumar Verma

steroidal 5α-reductase inhibitors 5α-reductase I 5α-reductase II 6-azasteroids electropositive substituents electronegative substituents baldness benign prostatic hyperplasia 5-alpha reductase inhibitors hair loss BPH

TLDR The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

The study successfully generated a 3D-QSAR comparative pharmacophoric model for both isoforms of steroidal 5α-reductase using 39 6-azasteroids. The model identified key structural features, including the importance of exchanging electropositive with electronegative substituents at specific positions (R1 and R2) and incorporating electropositive bulky substituents with non-bulky branching having electronegative functionality at R3. These findings provided a structural framework for designing new potent and selective inhibitors for both isoforms, aiding in the treatment of conditions like baldness and benign prostatic hyperplasia.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

6 / 6 results

research Steroidal 5α-Reductase and 17α-Hydroxylase/17,20-Lyase (CYP17) Inhibitors Useful in the Treatment of Prostatic Diseases

51 citations , May 2013 in “The Journal of Steroid Biochemistry and Molecular Biology”

Certain drugs that block specific enzymes can help treat prostate diseases.

research Synthesis and Biological Evaluation of Novel Unsaturated Carboxysteroids as Human 5α-Reductase Inhibitors: A Legitimate Approach

17 citations , June 2012 in “European journal of medicinal chemistry”

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

research The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

218 citations , December 2011 in “Advances in Urology”

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

research An Overview on 5α-Reductase Inhibitors

219 citations , October 2009 in “Steroids”

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

research The 5 Alpha-Reductase System and Its Inhibitors

124 citations , January 1996 in “Dermatology”

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

research Structure of Human Type II 5 Alpha-Reductase Gene

124 citations , September 1992 in “Endocrinology”

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Related Community Posts Join

6 / 870 results

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 1 year ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community 5 alpha reductase type 1 is in brain tissue producing the main endogenous gabaergic allopregnanolone, not 2. How can finasteride as a 5ar2 lower that?

in Finasteride/Dutasteride 25 upvotes 1 year ago

Finasteride and dutasteride are discussed for hair loss, with concerns about their effects on neurosteroids and potential side effects like depression. Alternatives like topical estrogen and lifestyle changes are considered, with varying opinions on mental health and hair regrowth.

community Using Fin and Alfatradiol in conjunction?

in Finasteride/Dutasteride 5 upvotes 4 years ago

User considers adding Alfatradiol to their topical finasteride treatment for hair loss. Others discuss Alfatradiol as a weak estrogen and 5α-reductase inhibitor used for pattern hair loss in men and women.

community Sugar and Hair loss connections

in Research/Science 41 upvotes 10 months ago

High sugar diets may worsen hair loss by increasing 5α-reductase activity and androgen levels, especially in women with PCOS. A low sugar diet might reduce scalp DHT levels, similar to finasteride, but genetics also significantly influence hair loss.

community Finasteride only reduces scalp DHT by ~40%. Why does it work?

in Finasteride/Dutasteride 37 upvotes 2 years ago

How Finasteride and Dutasteride help reduce hair loss by reducing the amount of DHT in scalp areas, as well as discussing factors such as sensitivity to DHT, 5α-reductase expression in different parts of the hair follicle, and scalp tension.

community Can I still save my hairline at age of 15?

in General 532 upvotes 4 months ago

A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

Related Research

1 / 1 results

research Establishment of Type II 5α-Reductase Over-Expressing Cell Line as an Inhibitor Screening Model

12 citations , June 2007 in “Journal of steroid biochemistry and molecular biology/The Journal of steroid biochemistry and molecular biology”

A reliable model for screening type II 5α-reductase inhibitors was created and validated.